AI Drug Discovery Unicorn Insilico Medicine Jumps In Hong Kong Trading Debut

Insilico Medicine aims to become a “huge source of innovative medicines for pharmaceutical companies” after raising $293 million in an initial public offering, founder Alex Zhavoronkov said.